Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 1, Pages 112
Publisher
MDPI AG
Online
2018-12-31
DOI
10.3390/ijms20010112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
- (2018) Akhileshwar Namani et al. BMC CANCER
- Letrozole may be a valuable maintenance treatment in high-grade serous ovarian cancer patients
- (2018) V. Heinzelmann-Schwarz et al. GYNECOLOGIC ONCOLOGY
- Effects of cigarette smoke extracts on apoptosis and oxidative stress in two models of ovarian cancer in vitro
- (2018) Cho-Won Kim et al. TOXICOLOGY IN VITRO
- Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy
- (2018) Sonali Bhattacharjee et al. Cancers
- Expression Patterns of Nrf2 and Keap1 in Ovarian Cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival
- (2017) Hye-yon Cho et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Synthetic lethality in DNA repair network: A novel avenue in targeted cancer therapy and combination therapeutics
- (2017) Sonali Bhattacharjee et al. IUBMB LIFE
- Ovarian Cancer: A Heterogeneous Disease
- (2017) Myriam Kossaï et al. PATHOBIOLOGY
- The role of sex hormones and steroid receptors on female reproductive cancers
- (2017) Luiz Gustavo de Almeida Chuffa et al. STEROIDS
- The KEAP1–NRF2 System in Cancer
- (2017) Keiko Taguchi et al. Frontiers in Oncology
- Endocrine therapy in epithelial ovarian cancer
- (2016) Simon P Langdon et al. Expert Review of Anticancer Therapy
- Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas
- (2016) Mohammad Reza Boustani et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The Dual Roles of NRF2 in Cancer
- (2016) Silvia Menegon et al. TRENDS IN MOLECULAR MEDICINE
- 17β-Estradiol up-regulates Nrf2 via PI3K/AKT and estrogen receptor signaling pathways to suppress light-induced degeneration in rat retina
- (2015) C. Zhu et al. NEUROSCIENCE
- MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
- (2015) Kai-Xuan Sun et al. Journal of Ovarian Research
- Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells
- (2015) In-geun Ryoo et al. Oncotarget
- Nrf2, the master redox switch: The Achilles' heel of ovarian cancer?
- (2014) Monique G.P. van der Wijst et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway
- (2014) C. Gorrini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival
- (2013) Chiara Gorrini et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
- (2013) Weiva Sieh et al. LANCET ONCOLOGY
- The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells
- (2013) Raymond Lo et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
- (2012) Miriam Lenhard et al. BMC CANCER
- Ten-Year Relative Survival for Epithelial Ovarian Cancer
- (2012) Lauren A. Baldwin et al. OBSTETRICS AND GYNECOLOGY
- When NRF2 Talks, Who's Listening?
- (2010) Nobunao Wakabayashi et al. ANTIOXIDANTS & REDOX SIGNALING
- The Nrf2-Keap1-ARE Signaling Pathway: The Regulation and Dual Function of Nrf2 in Cancer
- (2010) Donna D. Zhang ANTIOXIDANTS & REDOX SIGNALING
- Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
- (2010) John D. Hayes et al. ANTIOXIDANTS & REDOX SIGNALING
- Regulation of the Nrf2–Keap1 Antioxidant Response by the Ubiquitin Proteasome System: An Insight into Cullin-Ring Ubiquitin Ligases
- (2010) Nicole F. Villeneuve et al. ANTIOXIDANTS & REDOX SIGNALING
- High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
- (2010) T. Jiang et al. CANCER RESEARCH
- Accuracy and cut-off point selection in three-class classification problems using a generalization of the Youden index
- (2010) Christos T. Nakas et al. STATISTICS IN MEDICINE
- Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary
- (2009) Alexander Burges et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- Methoxychlor and Estradiol Induce Oxidative Stress DNA Damage in the Mouse Ovarian Surface Epithelium
- (2008) Daniel A. Symonds et al. TOXICOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started